Use of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery
This study retrospectively evaluates rFVIIa administration for the treatment of severe bleeding in pediatric patients immediately after cardiac surgical procedures requiring CPB.
